Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 Study.
Grenfell RFQ, Almeida NBF, Filgueiras PS, Corsini CA, Gomes SVC, de Miranda DAP, Lourenço AJ, Martins-Filho OA, de Oliveira JG, Teixeira-Carvalho A, Campos GRF, Nogueira ML, Alves PA, Fernandes GR, Castilho LR, Lima TM, de Abreu DPB, Alvim RGF, Silva TBS, Jeremias WJ, Otta DA, Campi-Azevedo AC; Immunita-001 Team. Grenfell RFQ, et al. Front Immunol. 2022 Jun 9;13:918896. doi: 10.3389/fimmu.2022.918896. eCollection 2022. Front Immunol. 2022. PMID: 35757764 Free PMC article. Clinical Trial.
Cytokine signatures of innate and adaptive immunity in 17DD yellow fever vaccinated children and its association with the level of neutralizing antibody.
Luiza-Silva M, Campi-Azevedo AC, Batista MA, Martins MA, Avelar RS, da Silveira Lemos D, Bastos Camacho LA, de Menezes Martins R, de Lourdes de Sousa Maia M, Guedes Farias RH, da Silva Freire M, Galler R, Homma A, Leite Ribeiro JG, Campos Lemos JA, Auxiliadora-Martins M, Eloi-Santos SM, Teixeira-Carvalho A, Martins-Filho OA. Luiza-Silva M, et al. J Infect Dis. 2011 Sep 15;204(6):873-83. doi: 10.1093/infdis/jir439. J Infect Dis. 2011. PMID: 21849284
Distinct pattern of immunophenotypic features of innate and adaptive immunity as a putative signature of clinical and laboratorial status of patients with localized cutaneous leishmaniasis.
Freitas-Teixeira PM, Silveira-Lemos D, Giunchetti RC, Baratta-Masini A, Mayrink W, Peruhype-Magalhães V, Rocha RD, Campi-Azevedo AC, Teixeira-Carvalho A, Martins-Filho OA. Freitas-Teixeira PM, et al. Scand J Immunol. 2012 Oct;76(4):421-32. doi: 10.1111/j.1365-3083.2012.02748.x. Scand J Immunol. 2012. PMID: 22823491 Free article.
17DD and 17D-213/77 yellow fever substrains trigger a balanced cytokine profile in primary vaccinated children.
Campi-Azevedo AC, de Araújo-Porto LP, Luiza-Silva M, Batista MA, Martins MA, Sathler-Avelar R, da Silveira-Lemos D, Camacho LA, de Menezes Martins R, de Lourdes de Sousa Maia M, Farias RH, da Silva Freire M, Galler R, Homma A, Ribeiro JG, Lemos JA, Auxiliadora-Martins M, Caldas IR, Elói-Santos SM, Teixeira-Carvalho A, Martins-Filho OA. Campi-Azevedo AC, et al. PLoS One. 2012;7(12):e49828. doi: 10.1371/journal.pone.0049828. Epub 2012 Dec 10. PLoS One. 2012. PMID: 23251351 Free PMC article. Clinical Trial.
Immunological profile of HTLV-1-infected patients associated with infectious or autoimmune dermatological disorders.
Coelho-dos-Reis JG, Passos L, Duarte MC, Araújo MG, Campi-Azevedo AC, Teixeira-Carvalho A, Peruhype-Magalhães V, Trindade BC, Dos Santos Dias R, Martins ML, Carneiro-Proietti AB, Guedes AC, Gonçalves DU, Martins-Filho OA. Coelho-dos-Reis JG, et al. PLoS Negl Trop Dis. 2013 Jul 25;7(7):e2328. doi: 10.1371/journal.pntd.0002328. Print 2013. PLoS Negl Trop Dis. 2013. PMID: 23936564 Free PMC article.
Gene expression profile of cytokines and chemokines in skin lesions from Brazilian Indians with localized cutaneous leishmaniasis.
Costa-Silva MF, Gomes LI, Martins-Filho OA, Rodrigues-Silva R, Freire Jde M, Quaresma PF, Pascoal-Xavier MA, Mendes TA, Serakides R, Zauli DA, Campi-Azevedo AC, Melo MN, Gontijo CM, Peruhype-Magalhães V, Teixeira-Carvalho A. Costa-Silva MF, et al. Mol Immunol. 2014 Feb;57(2):74-85. doi: 10.1016/j.molimm.2013.08.008. Epub 2013 Sep 28. Mol Immunol. 2014. PMID: 24084096
Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline.
Campi-Azevedo AC, de Almeida Estevam P, Coelho-Dos-Reis JG, Peruhype-Magalhães V, Villela-Rezende G, Quaresma PF, Maia Mde L, Farias RH, Camacho LA, Freire Mda S, Galler R, Yamamura AM, Almeida LF, Lima SM, Nogueira RM, Silva Sá GR, Hokama DA, de Carvalho R, Freire RA, Filho EP, Leal Mda L, Homma A, Teixeira-Carvalho A, Martins RM, Martins-Filho OA. Campi-Azevedo AC, et al. BMC Infect Dis. 2014 Jul 15;14:391. doi: 10.1186/1471-2334-14-391. BMC Infect Dis. 2014. PMID: 25022840 Free PMC article. Clinical Trial.
Etiological treatment of Chagas disease patients with benznidazole lead to a sustained pro-inflammatory profile counterbalanced by modulatory events.
Campi-Azevedo AC, Gomes JA, Teixeira-Carvalho A, Silveira-Lemos D, Vitelli-Avelar DM, Sathler-Avelar R, Peruhype-Magalhães V, Béla SR, Silvestre KF, Batista MA, Schachnik NC, Correa-Oliveira R, Eloi-Santos SM, Martins-Filho OA. Campi-Azevedo AC, et al. Immunobiology. 2015 May;220(5):564-74. doi: 10.1016/j.imbio.2014.12.006. Epub 2015 Jan 8. Immunobiology. 2015. PMID: 25648688
65 results